These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 17615292)

  • 1. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin.
    Shi H; Huang Y; Zhou H; Song X; Yuan S; Fu Y; Luo Y
    Blood; 2007 Oct; 110(8):2899-906. PubMed ID: 17615292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heparin binding motif of endostatin mediates its interaction with receptor nucleolin.
    Fu Y; Chen Y; Luo X; Liang Y; Shi H; Gao L; Zhan S; Zhou D; Luo Y
    Biochemistry; 2009 Dec; 48(49):11655-63. PubMed ID: 19877579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells.
    Zhuo W; Luo C; Wang X; Song X; Fu Y; Luo Y
    J Pathol; 2010 Nov; 222(3):249-60. PubMed ID: 20814900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear translocation of endostatin is mediated by its receptor nucleolin in endothelial cells.
    Song N; Ding Y; Zhuo W; He T; Fu Z; Chen Y; Song X; Fu Y; Luo Y
    Angiogenesis; 2012 Dec; 15(4):697-711. PubMed ID: 22711211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin.
    Huang XP; Wang X; Xie XL; Zhang GP; Lv FJ; Weng WT; Qiu F; Li ZF; Lin JS; Diao Y
    Oncotarget; 2018 Jan; 9(2):2220-2235. PubMed ID: 29416766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels.
    Christian S; Pilch J; Akerman ME; Porkka K; Laakkonen P; Ruoslahti E
    J Cell Biol; 2003 Nov; 163(4):871-8. PubMed ID: 14638862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature.
    Fogal V; Sugahara KN; Ruoslahti E; Christian S
    Angiogenesis; 2009; 12(1):91-100. PubMed ID: 19225898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostatin has ATPase activity, which mediates its antiangiogenic and antitumor activities.
    Wang S; Lu XA; Liu P; Fu Y; Jia L; Zhan S; Luo Y
    Mol Cancer Ther; 2015 May; 14(5):1192-201. PubMed ID: 25788476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endostatin inhibits the tumorigenesis of hemangioendothelioma via downregulation of CXCL1.
    Guo L; Song N; He T; Qi F; Zheng S; Xu XG; Fu Y; Chen HD; Luo Y
    Mol Carcinog; 2015 Nov; 54(11):1340-53. PubMed ID: 25175281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heat shock cognate 70 regulates the translocation and angiogenic function of nucleolin.
    Ding Y; Song N; Liu C; He T; Zhuo W; He X; Chen Y; Song X; Fu Y; Luo Y
    Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):e126-34. PubMed ID: 22743058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic targeting of angiogenesis with a recombinant CTT peptide-endostatin mimic-kringle 5 protein.
    Wang H; Yang Z; Gu J
    Mol Cancer Ther; 2014 Nov; 13(11):2674-87. PubMed ID: 25127900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted delivery of an antibody-mutant human endostatin fusion protein results in enhanced antitumor efficacy.
    Shin SU; Cho HM; Merchan J; Zhang J; Kovacs K; Jing Y; Ramakrishnan S; Rosenblatt JD
    Mol Cancer Ther; 2011 Apr; 10(4):603-14. PubMed ID: 21393427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endostatin signaling and regulation of endothelial cell-matrix interactions.
    Wickström SA; Alitalo K; Keski-Oja J
    Adv Cancer Res; 2005; 94():197-229. PubMed ID: 16096002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endostatin's endpoints-Deciphering the endostatin antiangiogenic pathway.
    Benezra R; Rafii S
    Cancer Cell; 2004 Mar; 5(3):205-6. PubMed ID: 15050911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
    Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
    Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
    Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear-translocated endostatin downregulates hypoxia inducible factor-1α activation through interfering with Zn(II) homeostasis.
    Guo L; Chen Y; He T; Qi F; Liu G; Fu Y; Rao C; Wang J; Luo Y
    Mol Med Rep; 2015 May; 11(5):3473-80. PubMed ID: 25607980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of DESI2 and endostatin gene therapy significantly improves antitumor efficacy by accumulating DNA lesions, inducing apoptosis and inhibiting angiogenesis.
    Yan H; Guo W; Li K; Tang M; Zhao X; Lei Y; Nie CL; Yuan Z
    Exp Cell Res; 2018 Oct; 371(1):50-62. PubMed ID: 30055135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of an
    Lam PY; Hillyar CR; Able S; Vallis KA
    J Labelled Comp Radiopharm; 2016 Oct; 59(12):492-499. PubMed ID: 27594091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.